PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummarySep 21, 2017	Integra LifeSciences Announces First Patient Enrolled in Cadence® Total Ankle System Post-Market Study PLAINSBORO, N.J., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced the first Cadence ® Total Ankle System has been implanted by Dr. David Pedowitz with the Rothman Institute in Philadelphia,	View HTML Integra LifeSciences Announces First Patient Enrolled in Cadence® Total Ankle System Post-Market Study 17.9 KB
Toggle SummarySep 23, 2013	Integra LifeSciences Announces First Implantation of Titan(TM) Reverse Shoulder System PLAINSBORO, N.J., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the first implantation of its Integra® Titan™ Reverse Shoulder System, in the United States. The system, which is used in the treatment of shoulder replacement surgery, was	View HTML Integra LifeSciences Announces First Implantation of Titan(TM) Reverse Shoulder System 10.9 KB
Toggle SummaryFeb 10, 2005	Integra LifeSciences Announces First Implantation of the HINTEGRA® Total Ankle Prosthesis in Brazil Integra LifeSciences Announces First Implantation of the HINTEGRA(R) Total Ankle Prosthesis in Brazil PLAINSBORO, N.J., Feb. 10, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the first three HINTEGRA® Total Ankle Prostheses, a product of	View HTML Integra LifeSciences Announces First Implantation of the HINTEGRA(R) Total Ankle Prosthesis in Brazil 13.5 KB
Toggle SummaryMar 13, 2014	Integra LifeSciences Announces First Implantation of Integra(R) Laminoplasty System PLAINSBORO, N.J., March 13, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the first implantation of its Integra® Laminoplasty System, in the United States. The system, which is used to treat patients with ossification of the posterior longitudinal	View HTML Integra LifeSciences Announces First Implantation of Integra(R) Laminoplasty System 11.4 KB
Toggle SummarySep 20, 2016	Integra LifeSciences Announces First Clinical Uses of Cadence™ Total Ankle System in Europe PLAINSBORO, N.J., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the first three procedures using the Integra® Cadence™ Total Ankle System in Europe were successfully completed since July	View HTML Integra LifeSciences Announces First Clinical Uses of Cadence™ Total Ankle System in Europe 12.6 KB
Toggle SummarySep 3, 2009	Integra LifeSciences Announces First Clinical Implant of INTEGRA(R) Dermal Regeneration Template for Life-Threatening Burns in Japan PLAINSBORO, N.J., Sep 3, 2009 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the first clinical implant of INTEGRA(R) Dermal Regeneration Template in Japan. The operation was performed by Dr.	View HTML Integra LifeSciences Announces First Clinical Implant of INTEGRA(R) Dermal Regeneration Template for Life-Threatening Burns in Japan 17.1 KB
Toggle SummaryJul 5, 2001	Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves PLAINSBORO, N.J., Jul 5, 2001 (BUSINESS WIRE) -- Product Launch to Begin in Fourth Quarter Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has received	View HTML Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves 13.3 KB
Toggle SummaryApr 12, 2011	Integra LifeSciences Announces FDA Clearance for New Indication for Accell Evo3(R) Demineralized Bone Matrix PLAINSBORO, N.J., April 12, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market Accell Evo3 ® Demineralized Bone Matrix as a bone void filler	View HTML Integra LifeSciences Announces FDA Clearance for New Indication for Accell Evo3(R) Demineralized Bone Matrix 10.8 KB
Toggle SummaryNov 13, 2014	Integra LifeSciences Announces FDA Clearance and Controlled Market Release of Expandable Interbody System for Spinal Surgery PLAINSBORO, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the controlled market release of the Integra ® Expandable Interbody System, in the United States. The system, which received 510(k) clearance from the United States Food and	View HTML Integra LifeSciences Announces FDA Clearance and Controlled Market Release of Expandable Interbody System for Spinal Surgery 11.6 KB
Toggle SummaryApr 23, 2002	Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures PLAINSBORO, N.J., April 23, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that the U.S.	View HTML Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures 13.1 KB
Toggle SummaryApr 4, 2017	Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan Financing now secured for the planned acquisition of Codman Neurosurgery	View HTML Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan 18.5 KB
Toggle SummarySep 1, 2015	Integra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion PLAINSBORO, N.J., Sept. 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. "We are pleased to improve our overall capital structure by expanding the size of	View HTML Integra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion 12.1 KB
Toggle SummaryDec 7, 2016	Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion PLAINSBORO, N.J., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. The expanded and extended credit facility includes the following terms: An increase	View HTML Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion 14.2 KB
Toggle SummaryJul 17, 2006	Integra LifeSciences Announces Exchange Offer for Its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008 Integra LifeSciences Announces Exchange Offer for Its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008 PLAINSBORO, N.J., Jul 17, 2006 (PRIMEZONE via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has commenced an offer to	View HTML Integra LifeSciences Announces Exchange Offer for Its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008 12.8 KB
Toggle SummaryJul 11, 2006	Integra LifeSciences Announces Direct Sales Strategy in Canada Integra LifeSciences Announces Direct Sales Strategy in Canada Acquires Canada Microsurgical Ltd. PLAINSBORO, N.J., July 11, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is launching a direct sales force in Canada through the acquisition of its	View HTML Integra LifeSciences Announces Direct Sales Strategy in Canada 10.6 KB